scanX
Jubilant Pharmova
add_icon

Jubilant Pharmova

1,017.55
+19.80
(1.98%)
Market Cap
16,207.65 Cr
PE Ratio
45.24
Volume
3,61,485.00
Day High - Low
1,023.50 - 989.05
52W High-Low
1,184.80 - 786.05
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
16,207.65 Cr
EPS
25.15
PE Ratio
45.24
PB Ratio
2.24
Book Value
445.26
EBITDA
1,325.80
Dividend Yield
0.50 %
Industry
Healthcare
Sector
Pharmaceuticals
Return on Equity
5.60
Debt to Equity
0.48
Analyst Rating and Forecast
- By Refinitiv from4 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+75.00 %
+75.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell+25.00 %
+25.00 %
Forecast For
Actual

Company News

View All News
Caret
negative
Jubilant Pharmova gets ₹87.31 crore GST notice for FY238 days ago
Jubilant Pharmova has received a GST demand notice of ₹87.31 crore from Mysore tax authorities pertaining to FY23, adding to its regulatory compliance obligations.
negative
Jubilant Pharmova faces ₹105.5 Cr GST demandAug 28, 2026
Jubilant Pharmova's subsidiary received a show cause notice from Roorkee GST authorities proposing a demand of ₹52.75 Cr in tax and an equal penalty for FY21 and FY22. The company contests the notice, citing legal errors.
positive
Jubilant Pharmova AGM: Resolutions Passed, Dividend ApprovedAug 26, 2026
Jubilant Pharmova shareholders approved all resolutions at the 48th AGM, including a ₹5 dividend. FY26 revenue grew 14% to ₹83 billion, with Q1FY27 up 17%. Directors reappointed.
View more

Peer Comparison Compare Peers on Screener

Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
Sun Pharmaceutical
1,876.50
#1 4,50,235.21
37.25
#1 61,673.90
12.69
#1 11,565
26.53
42.08
Divis Laboratories
9,454.50
2,50,987.27
86.86
11,067.00
13.95
2,568
65.50
73.44
Torrent Pharmaceuticals
4,948.50
1,88,225.03
87.56
13,886.20
20.34
2,138
3.28
51.61
Zydus Life Science
1,133.90
1,14,096.87
24.98
27,657.90
17.64
5,026
-34.90
50.98
Cipla
1,372.20
1,10,852.53
33.32
29,044.60
2.24
3,870
-39.18
37.48
Laurus Labs
1,932.20
1,04,311.09
96.41
6,867.80
22.01
890
#1 123.93
66.90
Aurobindo Pharma
1,680.60
96,698.01
26.14
34,145.20
5.56
3,503
25.21
60.75
Lupin
2,105.10
96,252.02
#1 17.40
29,038.90
#1 26.75
5,356
16.00
25.42
Dr Reddys Laboratories
1,146.30
95,678.12
30.19
35,058.60
3.90
4,158
-69.10
40.13
Mankind Pharma
2,296.80
94,856.92
46.06
14,636.40
14.85
1,938
29.13
36.72
Growth Rate
Revenue Growth
14.46 %
Net Income Growth
-52.47 %
Cash Flow Change
14.43 %
ROE
-58.24 %
ROCE
-44.84 %
EBITDA Margin (Avg.)
-5.86 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1,529
1,430
1,439
1,327
1,466
1,405
1,365
1,444
1,576
1,545
1,628
2,045
2,247
2,056
2,249
2,382
2,346
2,163
2,249
1,544
1,563
1,175
1,631
1,838
1,614
1,617
1,638
1,304
1,513
1,452
1,598
1,543
1,682
1,575
1,686
1,714
1,764
2,130
1,764
1,823
1,928
1,891
1,968
2,137
2,296
2,241
Expenses
1,323
1,121
1,129
1,061
1,192
1,051
1,045
1,126
1,293
1,219
1,336
1,651
1,794
1,663
1,828
1,899
2,262
1,747
1,798
1,141
1,131
977
1,242
1,293
1,216
1,269
1,319
1,116
1,280
1,259
1,440
1,408
1,459
1,419
1,439
1,459
1,656
1,480
1,477
1,554
1,587
1,611
1,631
1,873
1,964
1,981
EBITDA
206
309
310
266
274
354
319
318
283
327
293
394
453
393
422
483
83
415
451
403
432
199
389
546
398
348
319
187
233
192
158
134
223
156
247
255
108
650
287
269
341
280
337
264
332
260
Operating Profit %
13 %
21 %
21 %
20 %
19 %
25 %
23 %
22 %
17 %
21 %
18 %
19 %
19 %
19 %
19 %
19 %
4 %
19 %
20 %
24 %
24 %
13 %
20 %
26 %
22 %
21 %
19 %
14 %
15 %
13 %
9 %
8 %
12 %
9 %
14 %
12 %
5 %
14 %
15 %
14 %
17 %
14 %
17 %
12 %
14 %
11 %
Depreciation
66
70
75
75
127
72
72
73
75
73
79
82
182
88
90
98
95
103
117
84
98
82
85
96
86
88
100
93
101
95
94
94
271
90
97
95
101
91
91
91
95
98
105
121
117
127
Interest
85
91
92
89
99
83
80
98
80
69
66
77
73
51
54
53
62
73
72
49
47
48
47
46
43
35
35
37
40
40
42
51
56
62
66
71
73
71
61
56
53
49
50
56
57
54
Profit Before Tax
68
168
161
145
69
218
193
166
160
203
168
261
227
286
302
356
-40
269
292
294
358
106
299
431
297
247
208
70
106
69
36
9
-86
25
98
101
-54
500
144
131
206
154
190
93
176
86
Tax
25
37
36
24
58
54
50
48
11
60
43
48
74
86
92
88
61
84
43
90
98
18
75
121
83
86
65
19
47
22
32
25
14
19
36
35
8
18
42
30
55
52
70
38
57
30
Net Profit
43
130
125
122
11
164
144
118
149
144
126
213
152
200
210
268
-101
185
249
203
261
88
224
310
214
161
143
51
59
47
5
-16
-101
6
62
66
-62
482
103
101
151
103
120
56
119
56
EPS in ₹
2.68
8.28
8.11
7.90
0.72
10.39
9.29
7.66
9.63
9.44
8.23
13.64
9.94
13.00
13.50
16.74
-6.38
11.61
15.66
12.77
16.35
5.53
14.06
19.46
13.43
10.09
8.97
3.20
3.74
2.96
0.34
-0.98
-6.15
0.40
3.94
4.22
-3.69
30.44
6.47
6.37
9.71
6.49
7.59
3.52
7.55
3.57
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
8,619
8,824
9,041
9,618
11,469
12,522
8,918
9,991
11,157
11,549
12,756
15,523
Fixed Assets
4,911
5,104
5,107
5,401
5,648
6,340
4,609
4,871
5,183
5,091
5,176
6,966
Current Assets
2,715
2,875
2,948
3,190
4,585
5,038
2,953
3,509
3,762
3,876
3,577
4,109
Capital Work in Progress
597
611
684
671
901
768
897
1,090
1,562
2,103
3,630
4,040
Investments
0
85
103
124
115
69
241
239
256
42
44
61
Other Assets
3,111
3,023
3,147
3,423
4,804
5,344
3,171
3,792
4,156
4,312
3,907
4,455
Total Equity & Liabilities
8,619
8,824
9,041
9,618
11,469
12,522
8,918
9,991
11,157
11,549
12,756
15,523
Current Liabilities
2,129
2,464
1,684
2,005
2,090
2,619
1,049
1,592
1,772
1,889
2,165
2,539
Non Current Liabilities
4,036
3,432
3,968
3,578
4,570
4,299
3,128
3,083
3,993
4,238
4,353
5,888
Total Equity
2,454
2,928
3,389
4,035
4,809
5,604
4,742
5,316
5,392
5,421
6,239
7,096
Reserve & Surplus
2,438
2,951
3,421
4,071
4,793
5,588
4,726
5,303
5,383
5,418
6,239
7,077
Share Capital
16
16
16
16
16
16
16
16
16
16
16
16
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Net Cash Flow
-82
-52
117
-212
761
225
-652
482
30
-58
132
179
Investing Activities
-362
-309
-465
-614
-1,018
-267
-727
-323
-474
-596
513
-1,143
Operating Activities
783
1,099
1,269
1,303
1,122
1,543
1,784
838
661
971
1,072
1,227
Financing Activities
-503
-843
-686
-901
657
-1,050
-1,709
-33
-157
-433
-1,453
95
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Promoter
50.68 %
50.68 %
50.68 %
50.68 %
50.68 %
50.68 %
50.68 %
50.68 %
50.68 %
50.68 %
50.68 %
50.68 %
50.68 %
50.68 %
50.68 %
50.68 %
50.68 %
47.68 %
47.68 %
47.68 %
47.68 %
47.68 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
23.21 %
0.00 %
19.06 %
19.49 %
17.94 %
16.96 %
17.22 %
17.40 %
16.57 %
15.96 %
15.90 %
15.87 %
DIIs
0.78 %
1.15 %
0.40 %
0.43 %
0.05 %
0.04 %
0.39 %
1.62 %
0.40 %
1.63 %
1.65 %
1.50 %
3.78 %
4.07 %
5.66 %
6.98 %
7.05 %
9.53 %
10.52 %
11.22 %
11.62 %
12.40 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
1.24 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
16.07 %
16.98 %
19.03 %
18.97 %
19.27 %
19.35 %
19.01 %
18.68 %
18.69 %
18.25 %
18.24 %
18.76 %
18.71 %
17.79 %
18.09 %
18.09 %
17.75 %
17.97 %
18.02 %
17.85 %
17.57 %
17.16 %
Others
32.47 %
31.19 %
29.89 %
29.92 %
30.00 %
29.93 %
29.92 %
29.02 %
28.98 %
29.44 %
6.22 %
29.06 %
7.77 %
7.97 %
7.63 %
7.30 %
7.31 %
7.42 %
7.22 %
7.29 %
7.23 %
6.89 %
No of Share Holders
0
61,942
87,493
1,13,776
1,09,420
1,08,063
1,09,410
1,05,632
97,935
93,375
89,376
86,588
92,264
81,992
89,456
1,02,442
96,526
99,673
93,336
90,133
86,347
82,703

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 3 3 4.5 5 5 5 5 5 5 5
Dividend Yield (%) 0.36 0.45 1.81 0.73 1.29 1.79 0.88 0.56 0.61 0.5

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
01 Feb 2021 CHANGE OF NAME Change Of Name
NA
 01 Feb 2021 886.60 886.60
06 Aug 2021 DIVIDEND Dividend
₹ 5.00 /share
 05 Aug 2021 843.05 657.45
12 Aug 2022 DIVIDEND Dividend
₹ 5.00 /share
 11 Aug 2022 397.10 353.35
10 Aug 2023 DIVIDEND Dividend
₹ 5.00 /share
 10 Aug 2023 362.90 404.75
02 Aug 2024 DIVIDEND Dividend
₹ 5.00 /share
 02 Aug 2024 703.90 866.20
30 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
 30 Aug 2024 849.00 920.60
25 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 25 Oct 2024 1,228.25 1,108.05
31 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 31 Jan 2025 937.70 954.95
16 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 16 May 2025 896.35 905.60
25 Jul 2025 DIVIDEND Dividend
₹ 5.00 /share
 25 Jul 2025 905.60 1,175.00
29 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 29 Jul 2025 1,210.30 1,174.20
29 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
 29 Aug 2025 1,119.10 1,039.30
31 Oct 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 31 Oct 2025 1,097.50 1,118.40
06 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 06 Feb 2026 946.80 974.50
22 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 22 May 2026 946.30 1,011.65
24 Jul 2026 DIVIDEND Dividend
₹ 5.00 /share
 24 Jul 2026 1,011.65 970.85
10 Aug 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 10 Aug 2026 977.90 932.00
26 Aug 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
 26 Aug 2026 963.45 896.65

Announcements

Receipt Of Show Cause Notice By Jubilant Pharmova Limited - GST8 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication10 days ago
Receipt Of Show Cause Notice - Jubilant Generics LimitedAug 28, 2026
Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 26, 2026
Shareholder Meeting / Postal Ballot-Outcome of AGMAug 26, 2026
USFDA Approval For Line 3 Contract Manufacturing Facility Spokane U.S.AAug 23, 2026
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotAug 17, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportAug 17, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 11, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 10, 2026
Un-Audited Standalone & Consolidated Financial Results For The Quarter Ended June 30 2026Aug 10, 2026
Board Meeting Outcome for Meeting Held On August 10 2026Aug 10, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 05, 2026
Board Meeting Intimation for Postponement And Rescheduling Of Board Meeting Scheduled For August 10 2026Aug 05, 2026
Newspaper Advertisements Titled Notice Of 48Th Annual General Meeting E-Voting Record Date And Final Dividend InformationAug 02, 2026
Intimation To Shareholders About Deduction Of Tax At Source (TDS) On Final Dividend For FY 2025-26 If Approved By The Members At The Ensuing AGMAug 01, 2026
Intimation Regarding Letter Dispatched To The Shareholders Whose Email Ids Are Not Registered For AGM Notice TDS Communication And Annual Report Of The Company For FY 2025-26Aug 01, 2026
Business Responsibility and Sustainability Reporting (BRSR)Aug 01, 2026
Please Find Attached Herewith The Notice Of 48Th Annual General Meeting Alongwith The Annual Report For The Financial Year 2025-26. The 48Th AGM Of The Company Will Be Held On Wednesday August 26 2026 Through Video Conferencing / Other Audio Visual Means.Aug 01, 2026
Reg. 34 (1) Annual Report.Aug 01, 2026
Reg. 34 (1) Annual Report.Aug 01, 2026
Submission Of Copies Of Newspaper Advertisement Relating To Notice To Shareholders - Transfer Of Equity Shares/Dividend To IEPFJul 30, 2026
Board Meeting Intimation for Intimation Of Board Meeting Scheduled For August 07 2026Jul 30, 2026
Announcement Under Regulation 30 (LODR) - Communication Sent To Shareholders Relating To Notice Of Transfer To IEPFJul 29, 2026
Submission Of Copies Of Newspaper Publications - Annual General Meeting Of Jubilant Pharmova Limited Scheduled To Be Held On Wednesday August 26 2026 Through Video Conferencing/Other Audio Visual Means. Jul 29, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 19, 2026
Shareholder Meeting / Postal Ballot-Notice of Postal BallotJul 18, 2026
Rectification Order From The Income Tax DepartmentJul 16, 2026
Approval For Grant Of Stock Options/Rsus/PsusJul 16, 2026
Disclosure under Regulation 30A of LODRJul 16, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 02, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 01, 2026
Receipt Of Rectification OrderJun 30, 2026
Closure of Trading WindowJun 29, 2026
Tentative Approval For Panto-Prazole Sodium DRJun 26, 2026
Rectification Order Received From Tax Department In The Matter Of Jubilant Generics LtdJun 24, 2026
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Jun 19, 2026
Completion Of USFDA InspectionJun 19, 2026
USFDA Inspection Update - Contract Manufacturing Facility At Montreal CanadaMay 29, 2026
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2026
Earnings Call TranscriptMay 27, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 23, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 22, 2026
Tax Demand Order Received By Companys Step Down SubsidiaryMay 22, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 22, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMay 22, 2026
Announcement under Regulation 30 (LODR)-Change in DirectorateMay 22, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMay 22, 2026
Record DateMay 22, 2026
Corporate Action-Board approves DividendMay 22, 2026

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Abakkus Flexi Cap Fund Direct-Growth
0.66%
551866
0.66%
0.66%
JioBlackRock Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
-14642
-0.35%
-0.37%
JioBlackRock Sector Rotation Fund Direct-Growth
0.00%
-1020
-0.06%
-0.07%
DSP Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
-573
-0.35%
-0.37%
UTI Nifty 500 Index Fund Direct-Growth
0.04%
441
0.04%
0.04%
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.00%
-236
-0.04%
-0.04%
Zerodha Nifty MidSmallcap400 50:50 Index Fund Direct-Growth
0.00%
-231
-0.17%
-0.19%
Navi Nifty MidSmallcap 400 Index Fund Direct-Growth
0.00%
-150
-0.12%
-0.13%
DSP Nifty 500 Index Fund Direct-Growth
0.00%
-62
-0.04%
-0.04%
UTI Nifty500 Shariah Index Fund Direct-Growth
0.12%
-41
-0.01%
-0.02%
HDFC Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
0
0.00%
-0.35%
JioBlackRock Flexi Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bajaj Finserv ELSS - Tax Saver Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bajaj Finserv Healthcare Fund Direct-Growth
0.00%
0
0.00%
-0.87%
Bandhan Aggressive Hybrid Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.00%
0
0.00%
-0.46%
Bandhan Business Cycle Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bandhan Focused Fund Direct-Growth
0.00%
0
0.00%
-5.36%
Bandhan Healthcare Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bandhan Innovation Fund Direct-Growth
0.00%
0
0.00%
-0.89%
Bandhan Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
0
0.00%
-0.35%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.00%
0
0.00%
-0.04%
Bandhan Small Cap Fund Direct-Growth
0.00%
0
0.00%
-1.20%
Edelweiss Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
0
0.00%
-0.35%
Groww Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
0
0.00%
-0.35%

Technical Indicators

RSI(14)
Neutral
70.44
ATR(14)
Volatile
32.85
STOCH(9,6)
Neutral
77.38
STOCH RSI(14)
Overbought
100.00
MACD(12,26)
Bullish
13.49
ADX(14)
Weak Trend
16.06
UO(9)
Bearish
65.27
ROC(12)
Uptrend And Accelerating
13.34
WillR(14)
Overbought
-15.09
Bearish
2
Neutral
5
Bullish
2

About Jubilant Pharmova

Jubilant Pharmova Limited is an integrated global pharmaceutical and life sciences company. It operates in segments including Radiopharma, Allergy Immunotherapy, Contract Development and Manufacturing Organisation-Sterile Injectables, Generics, Contract Research, Development and Manufacturing Organisation, and Proprietary Novel Drugs. The company manufactures and supplies Active Pharmaceutical Ingredients, Solid Dosage Formulations, Radiopharmaceuticals, and...more
Website
https://www.jubl.com
Chairperson NameShyam S Bhartia
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Fundamental Screeners
Technical Screeners
Intraday Screeners
Price & Volume Screeners
Candlestick Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
Sensex Companies
Nifty 50 Companies
Nifty Next 50 Companies
Nifty Bank Companies
Finnifty Companies
Defence Stocks
Semi Conductor Stocks
Renewable Energy Stocks
AI Stocks
Cement Stocks
Penny Stocks
Multibagger Stocks
Breakout Stocks
Dividend Stocks
Large Cap Stocks
Mid Cap Stocks
Small Cap Stocks
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

© 2025 - 2026 Raise Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016 | SEBI Research Analyst Registration No: INH000023357 Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104